Darwins Erben : Evolutionstheorie heute

Rezensionen zu: Axel Meyer : Evolution ist überall : Gesammelte Kolumne ‚Quantensprung’ des Handelsblattes, Böhlau 2008, 158 Seiten gebunden, ISBN 978-3205777717, 19,90 Euro. Volker Storch, Ulrich Welsch & Michael Wink : Evolutionsbiologie, Springer, 2. Auflage 2007, 518 Seiten gebunden, ISBN 978-3540360728, 39,95 Euro. Andreas Sentger & Frank Wigger (Hg.) : Triebkraft Evolution : Vielfalt, Wandel, Menschwerdung, Spektrum 2008, 294 Seiten, Gebunden, ISBN 978-3827420008, 24,95 Euro. Sean B. Carroll : Die Darwin-DNA : Wie die neueste Forschung die Evolutionstheorie bestätigt, S. Fischer 2008, 320 Seiten, gebunden, ISBN 978-3100102317, 19,90 Euro. Manfred Grasshoff : Die Evolution, 2 Audio-CDs, Gesamtspielzeit 127 Minuten Vocalbar 2007, ISBN 978-3939696018, 25 Euro

Von Rüppells Blausteißpapagei bis zum Fuß des Archaeopteryx : ornithologische Notizen aus Frankfurts Geschichte

Die Vogelkunde besitzt in Frankfurt eine weitreichende Tradition. So zum Beispiel engagierten sich Naturforscher und -liebhaber schon lange vor Gründung der Universität im Jahre 1914 in Vereinigungen wie der Senckenberg Gesellschaft für Naturforschung (SGN, gegründet 1817) oder der Zoologischen Gesellschaft Frankfurt (ZGF, gegründet 1858). Biografi sche Skizzen zeichnen den Weg von den Pionierzeiten der Frankfurter Ornithologie bis heute nach

Woher kommen wir? : Neue Bücher zur Evolutionsbiologie ; [Rezension]

Rezensionen zu: Thomas Junker : Die Evolution des Menschen. Verlag C. H. Beck, München 2006 ISBN 978-3-406-53609-0, 127 Seiten, 7,90 Euro. Guillaume Lecointre, Hervé Le Guyader : Biosystematik. Verlag Springer, Heidelberg 2006. ISBN 978-3-540-24037-2. 696 Seiten, 39,95 Euro. Ulrich Kutschera : Evolutionsbiologie. 2. Auflage, Verlag Eugen Ulmer, Stuttgart 2006. ISBN 978-3-8252-8318-6 303 Seiten, 39,90 Euro. Volker Knoop, Kai Müller : Gene und Stammbäume. Verlag Elsevier/Spektrum, München 2006 ISBN 978-3-8274-1642-1. 310 Seiten, 29,50 Euro

Geordnete Verhältnisse : zwei neue Bücher aus dem Frankfurter Forschungsinstitut Senckenberg

Rezensionen zu: Evolution : die Theorie eines selbstverständlichen Prozesses / D. Stefan Peters. Basilisken-Presse, Rangsdorf, 2010. ISBN 978-3-941365-07-0, 103 Seiten. 18 Euro Paleogene Fossil Birds / Gerald Mayr. Springer Verlag, Berlin [u.a.], 2009. ISBN 978-3-540-89627-2, 275 Seiten. 119,95 Eur

Insight into the structure-property relationship of UO2_{2} nanoparticles

Highly crystalline UO$_{2}$ nanoparticles (NPs) with sizes of 2–3 nm were produced by fast chemical deposition of uranium(IV) under reducing conditions at pH 8–11. The particles were then characterized by microscopy and spectroscopy techniques including high-resolution transmission electron microscopy (HRTEM), X-ray diffraction (XRD), high-energy resolution fluorescence detection (HERFD) X-ray absorption spectroscopy at the U M$_{4}$ edge and extended X-ray absorption fine structure (EXAFS) spectroscopy at the U L$_{3}$ edge. The results of this investigation show that despite U(IV) being the dominant oxidation state of the freshly prepared UO$_{2}$ NPs, they oxidize to U$_{4}$O$_{9}$ with time and under the X-ray beam, indicating the high reactivity of U(IV) under these conditions. Moreover, it was found that the oxidation process of NPs is accompanied by their growth in size to 6 nm. We highlight here the major differences and similarities of the UO$_{2}$ NP properties to PuO$_{2}$, ThO$_{2}$ and CeO$_{2}$ NPs

The role of response modalities in cognitive task representations

The execution of a task necessitates the use of a specific response modality. We examined the role of different response modalities by using a task-switching paradigm. In Experiment 1, subjects switched between two numerical judgments, whereas response modality (vocal vs. manual vs. foot responses) was manipulated between groups. We found judgment-shift costs in each group, that is irrespective of the response modality. In Experiment 2, subjects switched between response modalities (vocal vs. manual, vocal vs. foot, or manual vs. foot). We observed response-modality shift costs that were comparable in all groups. In sum, the experiments suggest that the response modality (combination) does not affect switching per se. Yet, modality-shift costs occur when subjects switch between response modalities. Thus, we suppose that modality-shift costs are not due to a purely motor-related mechanisms but rather emerge from a general switching process. Consequently, the response modality has to be considered as a cognitive component in models of task switching

Implications of early respiratory support strategies on disease progression in critical COVID-19: a matched subanalysis of the prospective RISC-19-ICU cohort.

Uncertainty about the optimal respiratory support strategies in critically ill COVID-19 patients is widespread. While the risks and benefits of noninvasive techniques versus early invasive mechanical ventilation (IMV) are intensely debated, actual evidence is lacking. We sought to assess the risks and benefits of different respiratory support strategies, employed in intensive care units during the first months of the COVID-19 pandemic on intubation and intensive care unit (ICU) mortality rates. Subanalysis of a prospective, multinational registry of critically ill COVID-19 patients. Patients were subclassified into standard oxygen therapy ≥10 L/min (SOT), high-flow oxygen therapy (HFNC), noninvasive positive-pressure ventilation (NIV), and early IMV, according to the respiratory support strategy employed at the day of admission to ICU. Propensity score matching was performed to ensure comparability between groups. Initially, 1421 patients were assessed for possible study inclusion. Of these, 351 patients (85 SOT, 87 HFNC, 87 NIV, and 92 IMV) remained eligible for full analysis after propensity score matching. 55% of patients initially receiving noninvasive respiratory support required IMV. The intubation rate was lower in patients initially ventilated with HFNC and NIV compared to those who received SOT (SOT: 64%, HFNC: 52%, NIV: 49%, p = 0.025). Compared to the other respiratory support strategies, NIV was associated with a higher overall ICU mortality (SOT: 18%, HFNC: 20%, NIV: 37%, IMV: 25%, p = 0.016). In this cohort of critically ill patients with COVID-19, a trial of HFNC appeared to be the most balanced initial respiratory support strategy, given the reduced intubation rate and comparable ICU mortality rate. Nonetheless, considering the uncertainty and stress associated with the COVID-19 pandemic, SOT and early IMV represented safe initial respiratory support strategies. The presented findings, in agreement with classic ARDS literature, suggest that NIV should be avoided whenever possible due to the elevated ICU mortality risk

Increased risk of severe clinical course of COVID-19 in carriers of HLA-C*04:01

Background: Since the beginning of the coronavirus disease 2019 (COVID-19) pandemic, there has been increasing urgency to identify pathophysiological characteristics leading to severe clinical course in patients infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Human leukocyte antigen alleles (HLA) have been suggested as potential genetic host factors that affect individual immune response to SARS-CoV-2. We sought to evaluate this hypothesis by conducting a multicenter study using HLA sequencing. Methods: We analyzed the association between COVID-19 severity and HLAs in 435 individuals from Germany (n = 135), Spain (n = 133), Switzerland (n = 20) and the United States (n = 147), who had been enrolled from March 2020 to August 2020. This study included patients older than 18 years, diagnosed with COVID19 and representing the full spectrum of the disease. Finally, we tested our results by meta-analysing data from prior genome-wide association studies (GWAS). Findings: We describe a potential association of HLA-C*04:01 with severe clinical course of COVID-19. Carriers of HLA-C*04:01 had twice the risk of intubation when infected with SARS-CoV-2 (risk ratio 1.5 [95% CI 1.1-2.1], odds ratio 3.5 [95% CI 1.9-6.6], adjusted p-value = 0.0074). These findings are based on data from four countries and corroborated by independent results from GWAS. Our findings are biologically plausible, as HLA-C*04:01 has fewer predicted bindings sites for relevant SARS-CoV-2 peptides compared to other HLA alleles. Interpretation: HLA-C*04:01 carrier state is associated with severe clinical course in SARS-CoV-2. Our findings suggest that HLA class I alleles have a relevant role in immune defense against SARS-CoV-2. Funding: Funded by Roche Sequencing Solutions, Inc